| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 Mar 24 | ALGS Aligos Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.13 | 72,000 | 81.36 k | 72,000 |
| 28 Feb 24 | ALGS Aligos Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.96 | 16,428 | 15.77 k | 16,428 |
| 28 Feb 24 | ALGS Aligos Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.96 | 65,713 | 63.08 k | 65,713 |
| 28 Feb 24 | ALGS Aligos Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.96 | 75,183 | 72.18 k | 75,183 |
| 27 Feb 24 | ALGS Aligos Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 3.06 | 23,000 | 70.38 k | 0 |
| 27 Feb 24 | ALGS Aligos Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 3.06 | 92,000 | 281.52 k | 0 |
| 27 Feb 24 | ALGS Aligos Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 16.18 | 255,626 | 4.14 mm | 0 |
| 8 Sep 23 | ALGS Aligos Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.84 | 48,000 | 40.32 k | 48,000 |
